Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Eduard Hambartsoumian

Eduard Hambartsoumian

Fertility Center of Yerevan Armenia

Mark P. Trolice

Mark P. Trolice

Fertility CARE – The IVF Center USA

George R Attia

George R Attia

UHealth Reproductive and Fertility Center USA

Waseem Asghar

Waseem Asghar

Florida Atlantic University USA

Umit A Kayisli

Umit A Kayisli

University of South Florida USA

João Brito Jaenisch Neto

João Brito Jaenisch Neto

Mother of God Hospital Brazil

Sofía Soto-Rodriguez

Sofía Soto-Rodriguez

Repro-Support Medical Research Centre Japan

Waldemar Naves do Amaral

Waldemar Naves do Amaral

Federal University of Goiás Brazil

IVF 2019

Embryology and IVF 2019

Conference Series LLC Ltd is overwhelmed and delighted to announce the inception of the novel event “3rd World Congress on Embryology and In Vitro Fertilization”. The most awaited event would be staged during March 18-19, 2019, at New York, USA. With the theme upholding “Exploring the Novel Research & Techniques in Women Health”, the event is assured to bring forth transparent and significant changes in the Healthcare sector.

Scope of Embryology and In-Vitro Fertilization:

Embryology a branch of science deals with the morphological aspects of organismal development. The genomic and molecular revolution of the second half of the 20th century, together with the classic descriptive aspects of science that allowed greater integration in our understanding in many developmental events. Through such integration, modern embryology helps to provide practical knowledge that is applied to assisted reproduction, stem cell therapy, birth defects, fetal surgery and other fields.

Overview:

IVF 2019 aims to gather a large number of participants from all over the world in the related topics to address and discuss about the recent information, controversies and the future directions. It will be a good opportunity for us to update the relevant research data and their clinical applications and interactive moments which will clarify the uncertainties. This conference will offer an exciting, cutting edge program with a high profile, scientific international and speakers, with a wide range of concurrent sessions focusing on specialist areas in IVF and reproductive biology.

Why New York?

New York City has been called both the most economically powerful city and the leading financial center of the world. The city is home to the world's two largest stock exchanges by total market capitalization, the New York Stock Exchange and NASDAQ. Over 120 colleges and universities are located in New York City, including Columbia University, New York University, and Rockefeller University, which have been ranked among the top 35 in the world. Top-Rated Tourist Attractions in New York City are Statue of Liberty and Battery Park, Empire State Building, Central Park and Metropolitan Museum of Art, Broadway and Shubert Alley, Rockefeller Center and Fifth Avenue, Brooklyn Bridge, Times Square, Chrysler Building, New York Public Library, Solomon R. Guggenheim Museum, Wall Street and St Patrick's Cathedral, South Street Seaport.

Who should attend?

  • Pharmacologists
  • Ultra Sound Specialists
  • Clinical embryology
  • Infertility and IVF Units
  • Gynecologists
  • Obstetricians
  • Reproductive Endocrinologists
  • Internists
  • Hematologists
  • Reproductive Medicine Specialists
  • Reproductive Immunologists

Details of Embryology and IVF Conferences 2019 in New York:

Conference Series LLC Ltd is organizing Embryology and IVF Conferences in 2019 at New York, USA. We organize Medical Meetings in the fields related to Artificial Insemination, IVF Treatment, Frozen Embryo Transfer, Fertility Surgery, Assisted Hatching, Ovarian Reserve (AMH) Test, Karyomapping, PolScope Technology, In vitro Maturation Techniques, Assisted Reproductive Technology (ART), Aging and Reproduction, Cryopreservation Techniques in ART Success, Polycystic Ovarian Syndrome, Histopathology in Embryology, Early Birth, Embryo-Lab Quality, Epididymis and Infertility, Mitochondria in IVF, Single Embryo Transfer, Embryo Culture System, Oocyte and Embryo Vitrification, Quality Management in ART, ART Success: Evidence Based Medicine, Gamete Intrafallopian Transfer, Female Pelvic Medicine and Reconstructive Surgery, Fertility and Conception

Conference Name

            Place

            Date

Embryology and IVF 2019

    New York, USA

      March 18-19, 2019

 

CONFERENCE OPPORTUNITIES:

For Researchers and Faculty members:

  • Speaker presentations
  • Poster presentation
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association partnering
  • Collaboration proposals
  • Academic partnering
  • Group participation

For students and Research scholars:

  • Poster competition
  • Young Researcher Forum
  • Student attendee
  • Group registrations

For Business Delegates:

  • Speaker presentations
  • Symposium hosting
  • Book launch event
  • Networking opportunities
  • Audience participation

For product manufacturers:

  • Exhibitor and Vendor booths
  • Sponsorship opportunities
  • Product launch
  • Workshop organization
  • Scientific partnering
  • Marketing and Networking with clients

Sessions/Tracks

Conference Series LLC Ltd is overwhelmed and delighted to announce the inception of the novel event “3rd World Congress on Embryology and In Vitro Fertilization”. The most awaited event would be staged during March 18-19, 2019 at New York, USA. With the theme upholding “Exploring the Novel Research & Techniques in Women Health”, the event is assured to bring forth transparent and significant changes in the Healthcare sector.

Track 1: Fertility and Conception

Fertility is the natural ability to produce offspring. As a measure, fertility rate is the number of offspring born per mating pair, individual or population. Population growth is estimated by fertility, mortality and migration rates. Fertility is the main prime determinant of population growth, which is highly associated with family planning, literacy, urbanization, and expansion of health system. In many part its level is more than twice the replacement level. A significant decline in fertility mainly in the urban setting has been reported over the past decade. Total fertility rate was relatively low. However, there were a significant number of births among adolescent women.

Track 2: Placentation

Placentology evolving rapidly to our understanding of the molecular, cellular and epigenetic mechanisms which underlying normal placental development and placental pathophysiology is rapidly increasing and the making opportunities in prediction, prevention and treatment of this condition are expanding likewise. It is the only relatively recently that attention which has been directed to studies of the uterine side of the placenta to look for possible defects that might explain otherwise unexplainable pregnancy complications. Preeclampsia and intrauterine fetal growth retardation are the two such disorders in which new information has come to light by study of placental bed biopsies and occasional caesarean hysterectomy specimens.

Track 3: Implantation

Implantation takes place, when ovulation and fertilization occur. Implantation happens in early stage of pregnancy when the fertilized egg (zygote) travels down the fallopian tube to the uterus and attaches to the epithelium or uterine lining. It takes about 8 to 10 days for the fertilized egg to reaches to the uterus. During this time, it develops into a blastocyst through different stages of transformation beginning as a single cell dividing into 150 cells with an outer layer the trophoblast, a fluid-filled cavity the blastocoel, and a cluster of cells on the interior the inner cell mass. The tiny ball of cells is about a size of a poppy seed. It attaches to the epithelium during 4th week of gestation.

Track 4: Early Birth

Complications from the premature birth are to blame for the deaths of a third of the babies who die before their first birthday, As according to a new study on infant mortality, the study also shows that black women are more likely to lose their first babies to death as if they give birth in their late 20s rather than as teenagers. Both findings are contrary to conventional wisdom about the causes of infant mortality and its relationship to the teenage pregnancy. As pregnant women with periodontal disease are more likely to deliver a premature baby, we have made significant progress in learning that how to keep premature babies alive and well, but still there is less research that helps us to learn what causes premature birth.

Track 5: Embryo-Lab Quality       

Designing an IVF Laboratory requires expert’s skill and training. ART Laboratory is a resource for infertility and reproductive professionals. IVF Laboratories has become an integral part of all infertility and fertility clinics all over world. Infertility specialist planning for all to open new IVF units, setting up an ideal laboratory is the key to success in IVF. To design, built and setting up complete world class IVF centre or lab it is important turnkey project and we need an expert to take care of it. While setting up a state-of-the-art IVF lab one need to keep in mind experience of Fertility specialists, Fertility embryologists and the scientists who are the key factors for the IVF lab. Needs help to plan and design lab space that best fit for clinic. Every lab has its own unique features.

Track 6: Cleavage Stage Embryo

In most of the IVF clinics around the world, this quality assessment a precise embryo quality evaluation is of paramount importance to sustain successful in vitro relies mainly on morphological evaluation of cleavage stage embryos. Embryologists should able to correlate with the features observed at the optical microscopes with the implantation potential of each particular embryo. To achieve this goal, many of the scoring systems are based on the morphological features of dividing embryo have been developed. These embryo classification systems are based on the evaluation of number of blastomeres, degree of fragmentation, the symmetry of the blastomeres, the presence of multinucleation and the compaction status. It is very important that the features that are related to the implantation potential are assessed accurately and similarly.

Track 7: Epididymis and Infertility

Approximately 13-15% of couples will encounter fertility problems during the reproductive life. Factors involving males are responsible for infertility in approximately 20% of couples and are contributory in another 30–40% of couples. This means that factors Involving males and infertility are implicated in more than 50% of the difficulties couples encounter when attempting pregnancy. Diagnostic tools and therapies to treat female infertility are relatively well developed. However, many of the causes of male infertility are considered idiopathic. The spermogram is accurately assesses male fertility through an evaluation of the semen quality, sperm concentration, motility and morphology.

Track 8: Mitochondria in IVF

Mitochondria play a vital role in oocyte functions and they are critical an indicator of oocyte quality. It is important for fertilization and development into viable offspring. Quality-compromised oocyte is correlated with the infertility, developmental disorders, reduced blastocyst cell number and embryo loss in mitochondrial dysfunctions plays a significant role. Increasingly, women affected with metabolic disorders such as diabetes or obesity and oocyte aging are seeking treatment in IVF clinics to overcome the adverse effect of metabolic conditions on mitochondrial functions and new treatments have become available to restore oocyte quality. A new technology has opened up new possibilities for therapeutic advances which will increase the success rates for IVF of oocytes from women with compromised oocyte quality.

Track 9: Single Embryo Transfer

Embryo transfer refers the process of assisted reproduction in this embryos are placed into the uterus of a female with the intent to establish a pregnancy. This technique which is often used with in vitro fertilization (IVF) may be used in humans or in animals. Single embryo transfer significantly reduces the incidence of multiple pregnancies. Surprisingly, a case of heterotopic pregnancy experienced after a single embryo transfer caused by coincidental natural pregnancy during assisted reproductive technologies.

Track 10: Embryo Culture System

Embryo culture confers different stages of embryogenesis at embryo transfer. The main stages at which embryo transfer is performed are cleavage stage or the blastocyst stage .Embryo culture until the blastocyst stage gives a significant increase in live birth rate per embryo transfer, but also gives a decreased number of embryos available for transfer and embryo cryopreservation, the cumulative clinical pregnancy rates is increased with cleavage stage transfer. Transfer day 2 instead of day 3 after fertilization will have no differences in rate. Embryos culture can be performed in an artificial culture medium or in an autologous endometrial co culture. With artificial culture medium, there either be same culture medium throughout the period, or a sequential system will be used, in this embryo is sequentially placed in different media.

Track 11: Oocyte and Embryo Vitrification

Vitrification is a technology used in the embryo and egg freezing process so that they can be stored for later use. This technology has many uses outside of fertility care with egg and embryo freezing; it allows something with a crystalline structure to convert into something very smooth. Cryobiology has come up with 2 methods that work well with human embryos, slow freezing   and vitrification. Oocyte vitrification is followed by intracytoplasmic sperm injection leads to lower embryo developmental competence compared with when used fresh insemination methods. However, pregnancy and implantation rates become higher when embryos are transferred into a more receptive endometrium, free of the adverse effects of gonadotropin.

Track 12: Quality Management in ART

Quality Management in ART: This is easily adoptable ways to implement and improve formalized quality management systems. Essential to achieve the best practices and maintenance of formal regulatory certifications & together to know how experienced opinion leaders operating in key areas worldwide. The primary regulations in the ART field, with attention to quality management demands and the links specific requirements to practical steps for implementation. Unlike most medical laboratories that play a diagnostic role, laboratories for assisted reproductive technologies, ART laboratories, are involved in the treatment of infertile couples. Handling human gametes and producing human embryos in order to achieve much sought of pregnancies form the key tasks of an ART laboratory. The impact of the activities and possible risks makes it necessary to ensure the safety and reproducibility of all methods.

Track 13: ART Success: Evidence Based Medicine

Assisted reproductive technology (ART) refers to treatments which involve handling eggs and sperms or embryos outside the body this includes IVF and a few of its variations. These procedures which are usually paired with fertility drugs are to increase success rates and at about 22% of ART procedures result in the birth of a baby. ART procedures are medical procedure, expensive and have side effects. When more than one embryo is placed in the uterus, there is a possibility of a pregnancy with multiples if two or more implants successfully. But in case so far no long-term health effects have been connected to children born using ART procedures, and so many people with fertility problems, ART is the best way of having a biological child.

Track 14: Gamete Intrafallopian Transfer

Gamete intrafallopian transfer get involves a direct transfer of human gametes, sperm and oocyte into the fallopian tube. Its role in the treatment of infertile women with patent tubes has been established. Recent data demonstrate that a 34.4% clinical pregnancies are with the highest pregnancy rate achieved in infertile women is due to endometriosis or unexplained infertility. Gamete intrafallopian transfer (GIFT) is the tool of assisted reproductive technology against infertility. This technique allows fertilization to take place inside the woman's uterus. With the advances in IVF the GIFT procedure is used as less as pregnancy rates in IVF which tend to be equal or better and this do not require laparoscopy when the egg is put back.

Track 15: Female Pelvic Medicine and Reconstructive Surgery

Obstetrics and Gynecology is the most complete and reliable source of information on current developments in women's health care. According to population projections from the U.S. Census Bureau from 2010 to 2050 and published age-specific prevalence estimates for bothersome, symptomatic pelvic floor disorders and pelvic organ prolapse, the number of women with uterovaginal prolapse is expected gradually to increase from 3.3 to 4.9 million from 2010 to 2050. Whereas complete vaginal eversion is obvious, lesser degrees of prolapse and the presence of enterocele are more difficult to discern and require careful evaluation of all anterior, posterior, and apical compartment defects.

Track 16: Ovulation Induction

Ovulation induction treatments, also referred to as fertility drugs, are used to stimulate follicles in ovaries resulting in production of multiple eggs in one cycle. These medications also control time that you release eggs, or ovulate, so that sexual intercourse, intrauterine inseminations, and in vitro fertilization procedures can be scheduled at the most likely time to achieve pregnancy. Risks associated with use of ovulation induction medications include increase in chance for high order multiple births and development of ovarian cysts. Rare side effect that occurs is ovarian hyper stimulation syndrome; symptoms include severe pain in pelvis, abdomen and chest, nausea, vomiting, bloating, weight gain and difficulty in breathing.

Track 17: Artificial Insemination

Artificial insemination (AI) is that the deliberate introduction of sperm cell into a female's womb or cervix for the aim of achieving a physiological condition through in vivo fertilization. It is a fertility treatment for humans, and could be applied in animal breeding also. Artificial insemination could use motor-assisted fruitful technology, sperm cell donation and agriculture techniques. Insemination techniques on the market can be done by intracervical insemination and intrauterine insemination. The beneficiaries of insemination are ladies who need to convey birth to their own kid, who could also be in a very lesbian relationship, single ladies or ladies who are in a very heterosexual relationship but male partner suffers from male sterility. Intracervical insemination (ICI) is that the best and most typical insemination technique and might be utilized in the house for self-insemination without any caregiver help. Compared with natural insemination (i.e., insemination by sexual intercourse), artificial insemination will be costlier and additional invasive, and needs skilled help.

Track 18: IVF Treatment

In vitro fertilization (IVF) treatment is complex series of procedures used for fertility treatment or genetic problems and assist with the conception of a child. During in vitro fertilization, mature eggs were collected from ovaries and fertilized by sperm in a lab conditions. In vitro fertilization is the most effective form of assisted reproductive technology. During in vitro fertilization, eggs and sperm are brought together in laboratory glass dish to allow the sperm to fertilize an egg. Using in vitro fertilization, one can use any combination like own eggs and sperm or donor eggs and sperm. After in vitro fertilization, one or more fertilized eggs are placed in the uterus.

Track 19: Frozen Embryo Transfer

Frozen embryo transfer (FET) is a cycle where a frozen embryo of previous fresh IVF cycle is softened to liquid and transferred back into the woman's uterus. This means it doesn’t undergo another cycle of hormone stimulation and an egg collection .This cycles can be undertaken on natural cycle by using hormone preparation or ovulation induction. Embryo freezing gives more opportunities for pregnancy for each hormone stimulation cycle and egg collection. Frozen embryos are viable to the infinite time after the first freeze. Embryo transfer can be done either after a successful or unsuccessful in vitro fertilization due to their infinite viability. Freezing embryos previously was a very slow process. But now, the applications were changes and freezing was done by a very simple and easy method called vitrification (freezing of embryos using cutting edge technology).

Track 20: Fertility Surgery

In female fertility surgery following are the initial testing and assessment that a fertility specialist may recommend.  It involves the laparoscopy, surgery of endometriosis, surgery for Fallopian tubes, female micro surgery. This can be used for further investigating the cause of infertility or to overcome the problems making it difficult to conceive.

Track 21: Assisted Hatching

Assisted hatching is an advanced scientific technique which involves using a laser to gently thin the outer shell of the egg. In some cases, particularly in older women, the thickness of the outer shell is implantation if an embryo hatches out of the shell more easily, in such cases it may have a better chance of implanting inside the uterus. If they have 38 years of age and had an unsuccessful IVF treatment cycle, then recommend using Assisted Hatching.

Track 22: Ovarian Reserve (AMH) Test

Assisted hatching is a scientific technique used in In Vitro Fertilization, which improves implantation of embryos into woman’s uterine lining by creating an opening through which embryonic cells hatches out. Pregnancy doesn’t occur unless embryo hatches. Before embryo implantation, developing embryo must hatch out of its outer shell named as zona pellucida. Some embryos seem to have thicker shell that may decrease their ability to hatch and therefore reduce likelihood that they will implant. This may be due to age of woman or other, unknown reasons. The unfertilized egg is surrounded by zona pellucid. Zona pellucida allows only one sperm cell to enter and fertilizes egg. After fertilization, embryo begins to cleave into two, four and so on. Assisted hatching is performed on embryos at this early cleavage stage. Women aged >37 have tendency to produce oocytes with harder or thicker zona pellucida compared to younger women. Same applies to women with high level of follicle-stimulating hormone.

Track 23: Karyomapping

Pre implantation genetic diagnosis with Karyomapping is a highly sophisticated scientific technique which can test embryos for presence of a single gene disorder. This allows selection of embryos which are not affected by a specific disorder for embryo transfer during an IVF cycle, preventing the condition from being passed on to any future children. In vitro fertilization (IVF) is essential to carry out PGD. This process involves collecting several eggs from the ovaries and fertilizing them outside the body (in vitro) to produce several embryos. Each of the embryos can then be tested to find out which is healthy. Only embryos that are predicted to be free of genetic condition are transferred to the uterus and consequently if any pregnancy that begins has a low risk of being affected by disorder.

Track 24: PolScope Technology

PolScope or Oosight Technology is an advanced scientific technique that uses polarized light to study the genetic material in the egg and help to identify which eggs may have a better chance of implanting. It may also help with the ICSI process, as the scientist performing the procedure to see where the genetic material is located to avoid injecting through this spindle.

Track 25: In vitro Maturation Techniques

IVM is the technique of permitting the ovarian follicles and the oocytes inside the mature in vitro. It can be offered to women with infertility problems combined with IVF, offering women pregnancy without ovarian stimulation. The obstetric and perinatal outcome of births from IVM cycles is similar to those with ICSI treatments. However, IVM involves the use of invasive techniques, and this can harm the mother.

Track 26: Assisted Reproductive Technology (ART)

Assisted reproductive technology (ART) is a treatment used for infertility. It includes fertility treatments that handle both woman's egg and man's sperm. It works by removing eggs from woman's body. Eggs are then mixed with sperm to produce embryos. Embryos are then placed in woman's body. In vitro fertilization (IVF) is most common and effective type of assisted reproductive technology. Assisted Reproductive Technology includes in vitro fertilization-embryo transfer, gamete intrafallopian transfer, zygote intrafallopian transfer, and frozen embryo transfer. Approximately 99% of ART cycles performed are in vitro fertilization-embryo transfer. In vitro fertilization-embryo transfer helped many couples to conceive successfully. Assisted Reproductive Technology can be recommended when other fertility treatments were not successful or when there is severe male factor infertility, severe endometriosis or tubal obstruction.

Track 27: Aging and Reproduction

The main function of human reproduction is mainly influenced by age to produce sex cells and hormones. Aging process affects reproductive systems of both men and women. The most striking age related changes in female reproductive system occur at menopause, while changes in the male reproductive system occur more gradually over a longer period of time. Despite this, a modern technology has been unable to extend the reproductive system in women, and the age of onset of menopause remains remarkably constant. Although many factors contribute to the age-related decline in human fertility, data suggested that the maternal aging renders the most significant impact.

Track 28: Cryopreservation Techniques in ART Success

Cryopreservation or cryoconservation is a method where organelles, cells, tissues, animate thing matrix, organs or the other biological constructs liable to injury caused by unregulated chemical mechanics are preserved by cooling to terribly low temperatures. At low temperatures, any protein or enzymatic activity may cause injury to biological material which is effectively stopped. Cryopreservation strategies look forward to achieve low temperatures without changing further injury caused by formation of ice throughout phase change. Ancient cryopreservation has relied on coating fabric to be frozen with category of molecules termed cryoprotectants. New strategies are perpetually being investigated owing to inherent of many toxic cryoprotectants. By default, it ought to be thought of that cryopreservation alters or compromises the structure and performance of cells unless it's established otherwise for a specific cell population. Cryoconservation of animal genetic resources is that method during which animal genetic material is collected and kept with intention of conservation of breed.

Track 29: Polycystic Ovarian Syndrome

Polycystic ovary syndrome (PCOS) could be a set of symptoms because of elevated androgens (male hormones) in girls. Signs and symptoms of PCOS include irregular or no discharge periods, serious periods, excess body and facial hair, acne, girdle pain, issue obtaining pregnancy, and patches of thick, darker, velvety skin. Associated conditions include a pair of polygenic disease, obesity, preventative apnea, cardiovascular disease, mood disorders, and carcinoma. PCOS is because of a mix of genetic and environmental factors. Risk factors include fleshiness, not enough workouts, and a case history of somebody with the condition. Diagnosing relies on 2 of the subsequent 3 findings: no organic process, high steroid hormone levels, and sex gland cysts. Cysts could also be detectable by ultrasound. Different conditions that turn out similar symptoms include adrenal dysplasia, gland disease, and hyperprolactinemia.

Track 30: Histopathology in Embryology

Histopathology is the microscopic examination of tissues to study manifestation of diseases. Histopathology can also be done in embryos. Embryo histopathology is study of abnormal embryos or defectively developing embryos. It can be done in various ways like necropsy, autopsy, biopsy, checking for separation of eyelids, checking for presence of fingerprints, length of the embryo, external body form of the embryo, X-ray of the embryo, abnormalities of specific systems (central nervous system, cardiovascular system, musculoskeletal system, urogenital system, morphological disturbances in chromosomal abnormalities, metabolic abnormalities). The exact frequency for pathogenesis of congenital defects can be obtained only by the examination of embryo. However, some of the pathological disturbances can also be obtained from maternal examination.

Market Analysis

Embryology has become an important research area for studying the genetic control of the development process, its link to cell signaling, its importance for the study of certain diseases and mutations, and in links to stem cell research. As defined by WHO, infertility is a complex pathology that requires appropriate investigation and treatment. One of the most effective treatments is IVF and its related technologies these techniques cannot be replaced by other procedures and have resulted in the birth of more than 6 million babies throughout the world.

Glance at Market of Embryology:

The world's leading Embryology market has attracted the rising use of intra-cytoplasmic sperm injection (ICSI) for the treatment of infertility. The report in Human Reproduction shows that while ICSI use has leveled off in some regions, its use is approaching 100% of assisted reproduction cycles in the Middle East and a few countries in other regions, despite the fact that ICSI was developed for the treatment of male infertility, which is a factor in around 40% of couples seeking fertility treatment.  The global fertility testing devices market is broadly categorized into ovulation prediction kits and fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors and others. The ovulation prediction kits market held the larger share of the global fertility testing devices market in 2020. However, the fertility monitors market is estimated to grow at the higher CAGR from 2020 to 2025. The average cost of in vitro fertilization in the U.S. is currently about $14,000 to $18,000.

Statistics which shows growth in importance of In Vitro Fertility:

Infertility is one of the major concerns in the world. One out of six couples in the world suffers from some form of infertility. About 10% women aged 20-44 suffer from infertility. There are various causes for infertility which include physiological (20-30% cases), some cases include genetically induced disorders whereas sometimes it may be self-induced as in case of contraceptive surgeries. The market is driven by rising awareness amongst couples, a strong and developed health structure in developing nations, low cost treatment options available, and rise in the new methods like in vitro activation and surrogacy. The testing and treatment market is growing at a faster rate in males than females. The earlier social taboos among men regarding male fertility have been declining, leading to increase in the male infertility testing and treatment market.

Major associations supporting Embryology are:

  • Human Fertilization and Embryology Authority (HFEA)
  • American embryo Transfer Association (AETA)
  • International Embryo Transfer Society (IETS)
  • Canadian Embryo Transfer Association (CETA/ACTE)
  • Breed Associations-Canadian Embryo Transfer Association
  • European Union Tissues and Cells Directives (EUTCD)

Societies and Organizations supporting Embryology are:

  • British Society for Developmental Biology (BSDB)
  • International Society of Stem Cell Research (ISSCR)
  • International Society of Developmental Biologists (ISDB)
  • International Federation of Placenta Associations (IFPA)
  • Japanese Society of Developmental Biologists (JSDB)
  • Teratology Society (TS)
  • Alex's Lemonade Stand Foundation
  • Alliance for Aging Research
  • Alliance for Regenerative Medicine
  • ALS Association (Amyotrophic Lateral Sclerosis Association)
  • Alpha-1 Foundation Colleen M. Murphy

In Vitro Fertilization Journals List

Past Conference Report

In Vitro Fertilization 2018

IVF 2018 Report:

We gratefully thank all our wonderful Keynote and Plenary Speakers, Conference Attendees, Students, Media Partners and Associations for making IVF 2018 grand success.

The 2nd World Congress on Embryology and In vitro Fertilization hosted by the Conference series LLC Ltd was held during March 30-31 at Holiday Inn hotel, Orlando, USA based on the theme Exploring the Novel Research & Techniques in Reproductive Health ". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from the area of Embryology and IVF, who made this event a grand success.

REPROLIFE and CooperSurgical lnc participated as the exhibitors for IVF series conferences along with their company Research and Development Asscoiates.

Conference series expresses its gratitude to the conference Moderator, namely Dr. Deepak Donthi from East Carolina University, USA for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Conference series would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of IVF 2018

Eduard Hambartsoumian, Fertility Center of Yerevan, Armenia

George R Attia, UHealth Reproductive and Fertility Center, USA

Joao Brito Jaenisch Neto, Mother of God hospital, Brazil

Mark P Trolice, Fertility CARE – The IVF Center, USA

Conference series LLC Ltd offers its heartfelt appreciation to organizations such as our esteemed Media Partners, Exhibitors, and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. It also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Co-chairs who supported this event.

With the grand success of IVF 2018Conference series LLC Ltd is proud to announce the "3rd World Congress on Embryology and In vitro Fertilization " to be held March 18-19, 2019 at New York, USA.

Let us meet again IVF 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 18-19, 2019

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Day 1

Supported By

Gynecology & Obstetrics

Human Genetics & Embryology

Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol

Reproductive System & Sexual Disorders: Current Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

What People Say....

Thank you for the honor of participating in your wonderful conference and I look forward to being invited to future conference.

Speaker

Mark P. Trolice, MD, Director, Fertility CARE, USA

Great conference and friendship in the audience was wonderful means that everybody there were thirsty to share and to learn.

Speaker

João Brito Jaenisch Neto, Mother of God Hospital, Brazil

It was very good experience, I liked the environment and scientific discussion during the conference. It was organized very well.

Speaker

Waseem Asghar, Ph.D, Florida Atlantic University, USA